| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |